MariMed Inc. (OTCMKTS:MRMD – Free Report) – Equities researchers at Ventum Cap Mkts issued their FY2026 earnings estimates for MariMed in a research report issued to clients and investors on Thursday, November 7th. Ventum Cap Mkts analyst A. Semple expects that the company will post earnings per share of $0.00 for the year. Ventum Cap Mkts currently has a “Strong-Buy” rating on the stock.
MariMed Stock Performance
MRMD opened at $0.17 on Monday. MariMed has a twelve month low of $0.14 and a twelve month high of $0.39. The company has a current ratio of 1.55, a quick ratio of 0.73 and a debt-to-equity ratio of 1.01. The stock has a market cap of $63.33 million, a PE ratio of -5.55 and a beta of 2.80. The business’s 50 day moving average is $0.16 and its 200-day moving average is $0.19.
About MariMed
MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.
Featured Stories
- Five stocks we like better than MariMed
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- How to Capture the Benefits of Dividend Increases
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- ETF Screener: Uses and Step-by-Step Guide
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.
